newsfilter
← Latest News
GlobeNewswire·

Immutep Quarterly Activities Report Q2 FY26

Media Release Entered into strategic collaboration with Dr. Reddy's for commercialisation of eftilagimod alfa (efti) in all countries outside North America, Europe, Japan, and Greater ChinaIn January 2026, Immutep